Abstract The transcription factor Pax6 has been reported to specify neural progenitor cell fates during development and maintain neuronal commitments in the adult. The spatiotemporal patterns of Pax6 expression were examined in sagittal and horizontal sections of the embryonic, postnatal, and adult brains using immunohistochemistry and double immunolabeling. The proportion of Pax6-immunopositive cells in various parts of the adult brain was estimated using the isotropic fractionator methodology. It was shown that at embryonic day 11 (E11) Pax6 was robustly expressed in the proliferative neuroepithelia of the ventricular zone in the forebrain and hindbrain, and in the floor and the mesencephalic reticular formation (mRt) in the midbrain. At E12, its expression emerged in the nucleus of the lateral lemniscus in the rhombencephalon and disappeared from the floor of the midbrain. As neurodevelopment proceeds, the expression pattern of Pax6 changes from the mitotic germinal zone in the ventricular zone to become extensively distributed in cell groups in the forebrain and hindbrain, and the expression persisted in the mRt. The majority of Pax6-positive cell groups were maintained until adult life, but the intensity of Pax6 expression became much weaker. Pax6 expression was maintained in the mitotic subventricular zone in the adult brain, but not in the germinal region dentate gyrus in the adult hippocampus. There was no obvious colocalization of Pax6 and NeuN during embryonic development, suggesting Pax6 is found primarily in developing progenitor cells. In the adult brain, however, Pax6 maintains neuronal features of some subtypes of neurons, as indicated by 97.1% of Pax6-positive cells co-expressing NeuN in the cerebellum, 40.7% in the olfactory bulb, 38.3% in the cerebrum, and 73.9% in the remaining brain except the hippocampus. Differentiated tyrosine hydroxylase (TH) neurons were observed in the floor of the E11 midbrain where Pax6 was also expressed, but no obvious colocaliztion of TH and Pax6 was detected. No Pax6 expression was observed in TH-expressing areas in the midbrain at E12, E14, and postnatal day 1. These results support the notion that Pax6 plays pivotal roles in specifying neural progenitor cell commitments and maintaining certain mature neuronal fates.
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Introduction
Pax6 is a highly conserved transcription factor containing two N terminally located DNA binding motifs, a paired domain and a homeodomain, and one C terminal transactivation domain, the proline-serine-threonine rich domain (Osumi et al. 2008; Callaerts et al. 1997) . Among these motifs, the so-called paired domain is the characteristic feature of Pax6 which was originally identified in the D. melanogaster segmentation genes paired, gooseberry, and gooseberry neuro (Noll 1993) .The paired box (Pax) was found to be conserved across a wide variety of species from metazoans to humans (Burri et al. 1989) . In mammals, Pax6 is necessary for specifying the neuroectoderm fate from pluripotent embryonic cells (Zhang et al. 2010) , maintaining the neural stem/progenitor cell pool in the mitotically active germinal zone, and producing new neurons from the neural stem/progenitor cells (neurogenesis) (Osumi et al. 2008) . It is crucial for forebrain patterning (telencephalic and diencephalic regionalization) in the mouse (Osumi 2001; Manuel and Price 2005; Georgala et al. 2011) and Xenopus (Moreno et al. 2008) , and in defining the boundary between adjacent embryonic brain domains. For example, it defines the prosencephalon-mesencephalon boundary (Mastick et al. 1997) , the pallial-subpallial boundary (Georgala et al. 2011) , and rhombomeric boundaries within the hindbrain (Takahashi and Osumi 2011) . Pax6 expression starts as early as embryonic day 8 (E8) in a broad domain in the neuroepithelium in the mouse, at the time when the neural tube is closing. As neurodevelopment proceeds, Pax6 is expressed in the developing brain from the mitotic germinal zone to, later, widely distributed cell groups in the embryonic forebrain, hindbrain (Walther and Gruss 1991; Stoykova and Gruss 1994) , midbrain (Stoykova and Gruss 1994) , and in the adult brain (Stoykova and Gruss 1994) . The expression patterns of Pax6 in distinct regions of the brain throughout neurodevelopment are the basis of the putative Pax6 functions mentioned above. The pattern of Pax6 expression has been extensively studied in the embryonic and adult brain, but some of the data are inconsistent. Several studies have shown that Pax6 is transiently expressed in the ventral mesencephalon in the mouse (Stoykova and Gruss 1994) , chick (Schubert and Lumsden 2005) and alligator (Pritz and Ruan 2009), and that it could play a role in promoting the TH-positive neuronal yield of the mouse ventral midbrain in vitro (Spitere et al. 2008) , but other reports indicated that Pax6 is not expressed in the mesencephalon at E8 (Walther and Gruss 1991) , E12.5 and E14.5 (Georgala et al. 2011) , neither in the substantia nigra (SN) and ventral tegmental area (VTA) at E12 and E16 (Vitalis et al. 2000) . In situ hybridization signals for Pax6 mRNAs were not detectable in the hippocampus in the young adult mouse (Stoykova and Gruss 1994) , but one report indicated an intense expression of Pax6 in proliferating precursors of the adult dentate gyrus (Nacher et al. 2005) .
To investigate the spatiotemporal expression patterns of Pax6 throughout neurodevelopment from E11 to adult stages, Pax6 expression in the whole brain was analyzed in serial coronal and sagittal sections using immunohistochemistry. Pax6 expression and its colocalization with NeuN and TH in the brain were detected using double immunolabeling. The isotropic fractionator method (Herculano-Houzel and Lent 2005) was used to determine the proportion of cells immunoreactive for Pax6 and NeuN in brain homogenates.
Materials and methods
Animals
Adult C57/BL6 mice (10-12 weeks old) were obtained from the Animal Resources Centre (ARC), Australia. Mice were housed on 12-h light-dark cycles with free access to food and water. Embryos were obtained by pairing male and female mice. Everyday for 3 days, female mice were exposed to male urine-soaked dirty bedding materials to initiate estrus, and late in the afternoon on the third day, the females were paired with males. Early in the next morning, if a seminal plug was present, the date was designated E0. The care and handling of the adult animals and embryos prior to and during the experimental procedures was approved by the Animal Care and Ethics Committee of the University of New South Wales Australia (approval number 08/48B, 11/75A).
Tissue preparation
Preparation of the adult mouse brain tissues followed the procedures described by Liang et al. (2010) . Adult mice were anesthetized with a lethal dose of sodium pentobarbitone (0.1 ml, 200 mg/ml) and perfused through the left ventricle, first with 60 ml of 0.9% normal saline to flush the blood vessels quickly, followed by 80 ml of cold 4% paraformaldehyde (PFA, Sigma) in 0.1 M phosphate buffer (PB, pH 7.4). The brains were removed from the skull, postfixed in 4% PFA for 6 h at room temperature, followed by cryoprotection in 30% sucrose in 0.1 M PB (pH 7.4) overnight at 4°C.
The embryonic brain tissues were prepared in accordance with Vitalis et al. (2000) . Embryos at stages from E11 to E17 were used in the present experiment. Embryos of E11, E12 and E13 were dissected from deeply anesthetized mothers and immersion fixed in 4% PFA in 0.1 M PB for 5 days. Embryos from E14 to E17 and postnatal mice were firstly anesthetized and then perfused transcardially with normal saline, followed by 4% PFA in 0.1 M PB for 2 min. The brains were postfixed in 4% PFA and cryoprotected in 30% sucrose in 0.1 M PB.
Serial sagittal or coronal sections of the whole brain were cut at 40 lm thickness on a cryotome (Leica CM 1950) . Sections were mounted onto gelatinized slides and dried at room temperature overnight. The mounted sections were processed for immunocytochemistry or kept at -40°C for long-term storage.
Immunohistochemistry
Sections were treated with 10 mM citrate buffer (pH 6.0) at 95°C for 15 min for antigen retrieval, the endogenous Brain Struct Funct (2013) 218:353-372 355 peroxidase was quenched by 1% hydrogen peroxide in 50% ethanol for 30 min at room temperature. After washes in PBS, the sections were blocked for 3 h at room temperature in a blocking solution (Vitalis et al. 2000) containing 2% bovine serum albumin, 2% goat serum, 7% glycerol, and 0.2% Tween 20 (BS), followed by incubation at 4°C for 72 h with a rabbit polyclonal antibody against Pax6 (Chemicon, 1:600 dilution, 1.67 lg/ml). Control was achieved by substituting normal rabbit serum for Pax6 antibody at the same concentration (1.67 lg/ml). Sections were firstly incubated with goat anti-rabbit biotinylated antibody (Sigma, 1:200 dilution), and then exposed to ExtrAvidin peroxidase (Sigma, 1:1000 dilution), at room temperature for 2 h. The primary-secondary antibody conjugates were visualized by treatment for 2-5 min in 0.05 M Tris buffer (pH 7.5) containing 0.05% 3,3 0 -diaminobenzidine tetrahydrochloride (DAB, Sigma), 0.3% nickel ammonium sulfate, and 0.03% hydrogen peroxide. The color reaction was stopped with several washes of PBS. The sections were dehydrated with a graded ethanol series, cleared with xylene, and coversliped with DPX (Sigma).
Double immunolabeling
Sections were hydrated in PBS, quenched in 1% hydrogen peroxide, and blocked in the blocking solution as mentioned above. Sections were then incubated at 4°C for 72 h with a mixture of a rabbit anti-Pax6 antibody (Chemicon, 1:600 dilution) and a mouse anti-TH antibody (Sigma, 1:1600 dilution), or with a mixture of a rabbit anti-Pax6 antibody and a mouse anti-NeuN antibody (Sigma, 1:1600). The sections were incubated at room temperature for 2 h with secondary antibodies: a FITC anti-mouse antibody (Chemicon, 1:200 dilution) and a goat anti-rabbit biotinylated antibody (Sigma, 1:200 dilution). Sections were then exposed to the ExtrAvidin peroxidase (Sigma, 1:1000 dilution) at room temperature for 2 h. Sections were coverslipped with fluorescent mounting medium (Dako) and the fluorochrome FITC-labeled antibody was visualized and photographed under a fluorescent microscope (Olympus BX51) equipped with a Carl Zeiss camera (AxioCam HRc). After removal of the coverslip, the biotinylated antibody was finally visualized using the above protocol. The sections were dehydrated, re-coversliped and scanned with Aperio Digital Pathology Systems (ScanScope XT). Photographs of DAB-stained sections were treated with a computer program (Adobe Photoshop) to change the tone of the pictures and merged with corresponding fluorescence images (Yamada et al. 2005) .
Pax6, TH, and NeuN-labeled cells in the coronal and sagittal sections were mapped and analyzed with reference to the atlases of the developing and adult mouse brain (Franklin and Paxinos 2008; Paxinos et al. 2007) , the atlas of the developing rat nervous system (Ashwell and Paxinos 2008) , and the reports on Pax6 expression (Walther and Gruss 1991; Stoykova and Gruss 1994) . The nomenclature and abbreviations for neuronal groups are taken from Ashwell and Paxinos (2008) and Allen Brain Atlas Resources [Internet], Seattle (WA): Allen Institute for Brain Science (data available from: http://www.brain-map.org).
Isotropic fractionator
The total number of nuclei and the proportion of Pax6 and/ or NeuN-positive cells in each sample were determined using the isotropic fractionator method (Herculano-Houzel and Lent 2005) . After at least 14-day postfixation, the adult mouse brain was dissected into five regions: olfactory bulb, cortex, cerebellum, hippocampus, and remaining areas. The dissected regions were cut into thin slices to prepare suspensions of intact cell nuclei through mechanical dissociation in a dissociation solution (1% Triton X-100 in 40 mM sodium citrate), using Tenbroeck tissue grinder (glass homogenizer). The homogenates and the washes were collected for centrifuging at 4,0009g for 10 min. The supernatant was discarded carefully and the pelleted nuclei were suspended in PBS by gentle pipetting.
The proportion of Pax6-positive neurons was estimated by immunostaining of Pax6 and NeuN from a 500 ll aliquot of the nucleus suspension. The suspension was centrifuged, the supernatant removed, and the pellet resuspended in 0.2 M boric acid solution (pH 9.0) for antigen retrieval at 75°C for 1 h. The nuclei were again collected by centrifugation, washed in PBS, and incubated overnight at room temperature with an anti-NeuN mouse antibody (Sigma, 1:500 dilution) and an anti-Pax6 rabbit antibody (Chemicon, 1:300 dilution) in 10% goat serum. After washing three times in PBS, the suspension was incubated with FITC-conjugated goat anti-mouse antibody (Chemicon, 1:300 dilution) and Alexa Fluor 594 labeled goat anti-rabbit antibody (Invitrogen, 1:300 dilution) in 10% goat serum and 50% DAPI (4 0 ,6-diamidino-2-phenylindole, dilactate) (10 mg/l, Molecular Probes) at room temperature for 2 h. The cell nuclei were collected by centrifugation, washed three times in PBS, and suspended in PBS. After sufficient agitation, a 10 ll aliquot was taken to detect DAPI-stained nuclei, FITC labeled NeuN-positive nuclei, and Alexa Fluor 594 labeled Pax6-positive nuclei using a hemocytometer through fluorescence microscopy at 4009 magnification. At least 500 DAPI-stained nuclei were counted and the percentages of NeuN and/or Pax6-positive nuclei were determined from the DAPI bright blue-fluorescing nuclei.
The remaining nuclei can be collected for longterm storage (Herculano-Houzel and Lent 2005) . The suspension was spun down in a centrifuge, the supernatant discarded, and the pellents resuspend in 30% sucrose in PBS for equilibration overnight at 4°C. The nuclei were spun down again and resuspended in an antifreeze solution (30% glycerol and 30% ethylene glycol in 24 mM phosphate buffer) to equilibrate overnight at 4°C, and then stored at -20°C until the next use.
Results
Spatial distribution of Pax6 in the embryonic brains
In the sagittal sections of the embryonic brains, Pax6 expression was detected in the forebrain (telencephalon and diencephalon), midbrain (mesencephalon) and hindbrain (isthmus and rhombencephalon). In the telencephalon, Pax6 immunopositive cells were found in the nearly entire layer of the primordial cortex at E11-E13 (Fig. 1a1 , b1, c1), and in the ventricular zone (VZ) of the cortex at E14 onward (Fig. 1d1, e1, f1 ). In the diencephalon, it is prominently expressed in the pretectum (Fig. 1a2, b2 , c2, d2, e', f2) and prethalamus (Fig. 1a3, b3 , c3, d3, e2, f3), forming sharp boundaries with the mesencephalon at the posterior commissure (pc) and with the thalamus at the sulcus diencephalicus medius, respectively. In the midbrain, Pax6 is mainly expressed in the mesencephalic reticular formation (mRt) (Fig. 1a4, b4 , c4, d4, e3, f4). In the hindbrain, it is expressed in the VZ of the fourth ventricle (Fig. 1a5, b5 , c5, d5, e4, f'), and in the external granular layer (EGL) of the developing cerebellum (Fig. 1d5, e4 , f').
Temporal distribution of Pax6 in the embryonic, neonate, and adult brains At E11, Pax6 expression was widely distributed in the VZ in the forebrain and hindbrain, but not in VZ in the midbrain (Fig. 2a-e) . In the forebrain (telencephalon and diencephalon), Pax6 was expressed in nearly the whole layer of the VZ in the telencephalon (Fig. 2a-c , inset in Fig. 2g) , and in the pretectum (Fig. 2b -e, inset in Fig. 2g ) and prethalamus ( Fig. 2a-b,2h ) in the diencephalon. A higher level of Pax6 expression was observed in the rostral-lateral cerebral cortex (Fig. 2g) than in the caudalmedial cortex (Fig. 2h) . In the midbrain (mesencephalon), Pax6 was expressed in the (mRt) (arrow in Fig. 2c , inset in Fig. 2h ) and the floor of the mesencephalon (arrowhead in Fig. 2e') . In the hindbrain (rhombencephalon), it is mainly expressed in the ventricular zone (Fig. 2a-c , inset in Fig. 2k) .
From E12 onward, expression of Pax6 was observed not only in the neuroepithelia of the ventricular zone but also in the extensively distributed cell groups as neurodevelopment proceeds. The overall distribution of Pax6 in the cell groups of the embryonic, neonate, and adult brain was shown in Figs. 3e12, 4e13, e14 , 5, 6e15, e17, p1, 7adult, and summarized in Table 1 .
In the secondary prosencephalon, Pax6 is expressed in nearly the whole layer of dorsolateral prosencephalic neuroepithelium from E11 until E13. After E15, it is confined to the VZ and is maintained in the subventricular zone of the adult-mouse cortex. Pax6 cells were seen in the septum (medial septal nucleus and the lateral septal nucleus, intermediate part), piriform cortex, anterior olfactory nucleus, amygdaloid area, preoptic area (lateral preoptic area), ventral pallidum, globus pallidus, prethalamic eminence, and hippocampus (dentate gyrus) at E12; in the diagonal domain (nucleus of the horizontal limb of the diagonal band, nucleus of the vertical limb of the diagonal band), several cell groups of the amygdaloid area (anterior amygdaloid area, intercalated nuclei of the amygdala, and the central, medial, basolateral and basomedial amygdaloid nuclei), entopeduncular nucleus, olfactory tubercle at E13; in the taenia tecta (ventral and dorsal tenia tecta), glomerular layer of the olfactory bulb, and lateral hypothalamus (peduncular part of the lateral hypothalamus, juxtaparaventricular part of the lateral hypothalamus) at E15.
In the diencephalon, Pax6 is strongly expressed in the pretectum, thalamus (lateral habenular nucleus and medial habenular nucleus), and prethalamus (pregeniculate nucleus, subgeniculate nucleus, zona incerta, and reticular thalamic nucleus) at E12. At later stages of the development, Pax6 expression is detected in many differentiating structures: the anterior pretectal nucleus, lateral nuclei (lateral posterior thalamic nucleus and laterodorsal thalamic nucleus), and subparafascicular thalamic nucleus, parvicellular part, at E13; the magnocellular nucleus of the posterior commissure, the nucleus of the posterior commissure, precommissural nucleus, and the nucleus of the field of Forel at E15.
Pax6 expression in regions of the embryonic forebrain brains was mostly maintained in these same regions in the adult brain, except for the dentate gyrus, globus pallidus, and lateral thalamic nuclei (lateral posterior thalamic nucleus and laterodorsal thalamic nucleus).
In the mesencephalon, Pax6 expression was observed in the mesencephalic reticular formation at E12, in the interstitial nucleus of Cajal and periaqueductal gray at E13, and persisted in all of these cell groups in the adult midbrain.
In the rhombencephalon, Pax6 was expressed in the nucleus of the lateral lemniscus, external granular layer of the developing cerebellum, superior and medial vestibular nucleus, and gigantocellular reticular nucleus at E12; in the pontine nuclei, dorsal raphe nucleus, central gray, isthmic reticular formation, reticulotegmental nucleus of the pons, ventral and dorsal cochlear nucleus, inferior olivary nucleus, and medioventral periolivary nucleus at E13; in the lateral reticular nucleus, external cuneate nucleus, nucleus X, median raphe nucleus, laterodorsal and posterodorsal tegmental nuclei, motor trigeminal nucleus (parvicellular part), and linear nucleus at E15. In the adult hindbrain, no obvious expression of Pax6 was observed in the median raphe nucleus, lateral reticular nucleus, external cuneate nucleus, motor trigeminal nucleus (parvicellular part), inferior olivary nucleus, medioventral periolivary nucleus, and gigantocellular reticular nucleus. (Fig. 8a) . At E15, more NeuN-positive cells were observed in the cerebral cortex (Fig. 8b) , amygdaloid area (Fig. 8c) , and juxtaparaventricular part of lateral hypothalamus (Fig. 8d) . Within all of these locations, no obvious Pax6 protein was observed to co-localize with NeuN. artificially changed to red using Adobe Photoshop. Pax6 expression was detected in the TH-positive floor of the mesencephalon at E11, but these two proteins were not found to be co-localized in the same cell (Fig. 9a) . Pax6 expression was not observed in the TH-positive substantia nigra (SN) and ventral tegmental area (VTA) at E12 ( Fig. 9b) , P1 (Fig. 9c) , and E14 (SN in Fig. 9e ; VTA in Fig. 9f ). Pax6 is not expressed in the TH-positive locus coeruleus (LC) of the rhombencephalon at P1 (Fig. 9d) .
Quantification of Pax6-positive cells in the adult brain
The proportions of Pax6-positive cells in four regions of the adult brain (olfactory bulb, cortex, cerebellum, and the remaining areas excluding hippocampus) were measured by the isotropic fractionator method ( 
Discussion
Pax6 is a highly conserved transcription factor that is involved in regulation of neural proliferation and neuronal differentiation (Osumi et al. 2008) . Numerous reports in many species, including human (Terzic and Saraga-Babic 1999; Mo and Zecevic 2008) , mouse (Walther and Gruss 1991; Stoykova and Gruss 1994; Puelles et al. 2000) , chick (Kawakami et al. 1997; Puelles et al. 2000) , turtle (Metin et al. 2007) , zebrafish (Hauptmann and Gerster 2000) , lamprey (Osorio et al. 2005) , and Xenopus (Moreno et al. 2008) have validated the evolutionary conservation in its expression in the brain. In the present study, the spatial and temporal expression patterns of Pax6 in the mouse brain were analyzed by immunostaining sagittal and coronal sections of embryonic (E11-E17), neonate, and adult brains. We found that Pax6 is intensely expressed in the embryonic brain from the most rostral part, the telencephalon, to the caudal part, the rhombencephalon, and that the overall spatial patterns remain mostly the same throughout neurodevelopment until the adulthood. Pax6 expression was first detected in the presumptive forebrain and hindbrain of the mouse at E8 (Walther and Gruss 1991) , at the time when the neural tube is closing and the tube wall consists entirely of proliferating neuroepithelial cells (Osumi et al. 2008) . At E10, the neural tube is regionalized to form the forebrain, midbrain, and hindbrain. The forebrain (prosencephalon) consists of the secondary prosencephalon and the diencephalon (Allen Brain Atlas Resources, data available from: http://www. brain-map.org). The secondary prosencephalon includes the preoptic area, prepeduncular (rostral) and peduncular (caudal) hypothalamus, and telencephalic vesicle. The diencephalon is divided into prosomere 1 (p1) (pretectum and pretectal tegmentum), p2 (thalamus and thalamic tegmentum, plus the habenula or epithalamus), and p3 (prethalamus and prethalamic tegmentum) (Puelles and Rubenstein 2003) .
Expression of Pax6 in the forebrain
In the secondary prosencephalon, we found that Pax6 is expressed in nearly the whole layer of dorsolateral prosencephalic neuroepithelium at E11 until E13, and it is confined to the VZ after E15. It is reported that the neural progenitor cells (neuroepithelial cells and radial glial cells) that divide at the ventricular surface strongly express Pax6 and exhibit astroglial properties (Osumi et al. 2008) . Our data showed that Pax6-positive cells in the neuroepithelium and VZ are negative for NeuN expression, thus these cells not only could be progenitor cells (with mitotic potential) but also could be glial cells or progenitor cells with astroglial properties. The expression levels of Pax6 appear to be essential for controlling the balance between neural stem-cell self-renewal and neurogenesis, either reducing Gi Fig. 3j1 , m Fig. 4b2, c2 , g2, i2, k2 Fig. 6f , j, l neocotical neural stem-cell self-renewal and thereby resulting in excess early neurogenesis at a lower level, or promoting neurogenesis at the expense of the self-renewal at a higher level (Sansom et al. 2009 ). In the current study, the Pax6 expression gradient (high in the rostral-lateral area and low in the caudal-medial area) was consistent with the report by Muzio and Mallamaci (2003) . The graded expression pattern of Pax6 in E11.5 mouse neocortex, (from a high level of expression at rostro-lateral areas to a low level of expression caudo-medial areas) indicates that Pax6 might contribute to the specification of rostral and lateral cortical domains, such as the primary motor cortex and the primary somatosensory cortex. Indeed, the absence of Pax6 in mice produced marked compression of rostral cortical areas at the level of the motor cortex (Muzio and Mallamaci 2003; Georgala et al. 2011 ). Moreover, it has been shown that Pax6 plays a role in axon guidance between the cortex and subcortical cell groups; in Pax6-null mutants, the majority of thalamocortical axons fail to enter the ventral telencephalon and those that do are unable to innervate their cortical targets in (Georgala et al. 2011) . Expression of Pax6 is maintained in the SVZ of the adult mouse cortex, and we found that 61.7% of the Pax6-positive cells are negative for NeuN, indicating their proliferative potential in the adult SVZ. Unlike to the situation in the embryonic brain, the remaining 38.3% of Pax6-positive neurons in the adult cortex co-express NeuN.
Pax6 is selectively required for the specification of several amygdaloid nuclei (Tole et al. 2005) . The severity of the Pax6-null mutant phenotype depends on the level of Pax6 expression, and it is highly critical for development of the lateral and basolateral amygdaloid nuclei (with a high level of Pax6 expression), moderately important for the basomedial nucleus (low expression), and less important for the medial amygdaloid nucleus nuclei MeP and MeD (extremely low expression) (Tole et al. 2005) .
In other areas of the prosencephalon, Pax6 expressing cells are mainly localized to post-mitotic cell groups in restricted domains: these include the taenia tecta, septum and diagonal domain, entopeduncular nucleus, piriform cortex, anterior olfactory nucleus, olfactory tubercle, preoptic area, hippocampus (dentate gyrus), and lateral hypothalamus. These expression patterns are mostly consistent with the previous reports (Walther and Gruss 1991; Stoykova and Gruss 1994; Kawakami et al. 1997) .
We found that expression of Pax6 in the taenia tecta and lateral hypothalamus emerged at E15, which is consistent with the fact that Stoykova and Gruss (1994) found this expression in the E13 embryo. Pax6 expression was mostly maintained in corresponding nuclei in the adult brain, except in the dentate gyrus, globus pallidus, and lateral nuclei (lateral posterior thalamic nucleus and laterodorsal thalamic nucleus). However, the intensity of Pax6 was much weaker in adult specimens. Pax6 expression is not observed in the adult dentate gyrus and globus pallidus, confirming the report by Stoykova and Gruss (1994) , but this disagrees with a report of intense expression of Pax6 in proliferating precursors of the adult dentate gyrus (Nacher et al. 2005) .
In the diencephalon, we found that Pax6 is strongly expressed in the pretectum, thalamus (lateral and medial habenular nucleus), and prethalamus (pregeniculate nucleus, subgeniculate nucleus, zona incerta, and reticular thalamic nucleus) at E12, and all the expressions persisted until the adulthood. The expression borders of the pretectum and prethalamus coincide with prosomeric boundaries within the diencephalon and the boundary between diencephalon and mesencephalon, respectively (Walther and Gruss 1991; Stoykova and Gruss 1994 ). Pax6 appears to be important for this boundary formation, and null mutants have a deficit in posterior commissure axons, a landmark of the boundary between prosencephalon and mesencephalon (Mastick et al. 1997 ).
Expression of Pax6 in the midbrain
In the mesencephalon, we found that Pax6 was not expressed in the VTA and SN from E12 onwards, confirming the observations reported in the E12 mouse brain by Vitalis et al. (2000) . Pax6 expression was observed in the floor of the E11 mesencephalon, and TH expressing cells were not coincident with those that expressed Pax6 in this location. In the zebrafish ventral thalamus, Pax6 cells were found to have close spatiotemporal association with TH cells but they were not double-labeled (Wullimann and Rink 2001) . However, in the mouse alar plate ventral thalamus (future zona incerta), Pax6 cells indeed develop into dopaminergic neurons (Vitalis et al. 2000) . In the Pax6 homologous deficient mutants, TH neurons in VTA were reduced by 75% at E11.5, and TH neurons in SN were accentuated at the p1-p2 border at E16.5 (Vitalis et al. 2000) . Therefore, Pax6 expression in the floor of the mesencephalon (without co-localization of TH) at E11 seems to drive the production of TH neurons. This inductive action may be cell autonomous, in which case, early Pax6 expression in the future TH cells would down-regulate before the TH phenotype appears in these cells. Alternatively, Pax6 cells might act inductively (cell-tocell) on the development of TH cells in this region (i.e., in a non-cell autonomous manner) (Wullimann and Rink 2001) . Pax6 is also necessary for correct pathfinding of the dopaminergic fibers along the medial forebrain bundle ventrally, because the homozygous Pax6-deficient mouse displayed a dorsally misrouted pathway of the fibers along the boundary between the pretectum and thalamus (Vitalis et al. 2000) . The abnormal location and defective ascending pathway of TH neurons were thought to be non-cell autonomous defective, since, SN-VTA neurons do not express Pax6 at E12 but the dorsorostrally deflected SN-VTA projections cross-regions that do express Pax6 (Georgala et al. 2011) .
Pax6 is also expressed in the deep mesencephalic nucleus (DpMe) in the E12.5 embryo (Vitalis et al. 2000) and the young adult mouse (Stoykova and Gruss 1994) , and in the mesencephalic tegmentum and differentiating SN at E13 (Stoykova and Gruss 1994) . We found that Pax6 is expressed in a similar area in the mesencephalic tegmentum throughout the development. The term DpMe has recently been abandoned in the most widely cited rodent brain atlas, and it is now named the mRt . Likewise, other parts of the reticular formation were named isRt in the isthmus and r1Rt in rhombomere 1 (r1) according to their neuromeric location Ashwell and Paxinos 2008) . The present study did not reveal Pax6 expression in the mesencephalic tegmentum and differentiating SN, at variance with results reported by Stoykova and Gruss (1994) .
Expression of Pax6 in the hindbrain
New gene expression data have forced major changes in nomenclature regarding the developing and adult hindbrain (Puelles et al. 2007 ). Gene expression reveals the presence of an isthmic region between the midbrain and the first rhombomere (Watson 2010) , and the remainder of the axial hindbrain should be termed the rhombencephalon (rhombomeres 1-11) (Puelles et al. 2007) . As a consequence, the old terms metencephalon and mylencephalon should now be abandoned. The old metencephalon corresponds to the isthmus and rhombomeres 1 and 2, and the old myelencephalon corresponds to rhombomeres 3-11. In the adult brain, the terms pons and medulla oblongata have been used to subdivide the hindbrain, but the variable size of the basilar pons in mammals makes this usage very unhelpful. In traditional human-brain terminology, the term pons represents the part of the hindbrain from the midbrain to the seventh rhombomere, whereas in the mouse, the basilar pons is located only in rhombomeres 3 and 4 (Puelles et al. 2007 ). Finally, it should be noted that the cerebellum in mammals arises from the isthmus and the first rhombomere (Sillitoe et al. 2012) .
A previous study (Walther and Gruss 1991) did not detect Pax6 expression rhombencephalon until E15.5, but we found expression in the nucleus of the lateral lemniscus as early as E12. Pax6 expression is clearly seen in the rhombic lip and its diversely distributed derivatives in the hindbrain throughout the development, including the major precerebellar nuclei (the pontine nuclei, reticulotegmental nucleus of the pons, lateral reticular nucleus, inferior olivary nucleus, external cuneate nucleus, and motor trigeminal nucleus, parvicellular part), hindbrain sensory nuclei (the cochlear nuclei, vestibular nuclei, and nucleus X), hindbrain monoamine nuclei (the median raphe nucleus, dorsal raphe nucleus, and locus coeruleus), and others (dorsal nucleus of the lateral lemniscus, paralemniscal nucleus, laterodorsal tegmental nucleus, gigantocellular reticular nucleus, and linear nucleus). The linear nucleus of the hindbrain is a rostrodorsal extension of the lateral reticular nucleus (Fu et al. 2009 ). The expression pattern of Pax6 in the embryonic hindbrain is maintained in the adult brain. Of the adult total cerebellar cells, 70.6% express Pax6 and 97.1% of Pax6-positive cells co-express NeuN.
Pax6 is expressed in the upper rhombic lip-derived external granular layer of the developing cerebellum and maintained in the adult cerebellar granule cells. It is critical for the morphogenesis of the entire cerebellum, because, a mutation in Pax6 results in not only a decreased neuronal differentiation and an increased proliferation of granule cell precursors in vitro but also a disruption of signaling from the external granular layer of developing cerebellum to Purkinje cells in vivo (Swanson et al. 2005) .
Pax6 is expressed in the lower rhombic lip-derived neurons, mossy fiber neurons (the pontine gray, reticulotegmental nucleus of the pons, lateral reticular nucleus, external cuneate nucleus) and climbing fiber neurons (inferior olivary nucleus). The mossy fiber neurons project to the cerebellar granule cells, which are characterized by expression of the proneural bHLH transcription factor, Math1 (Landsberg et al. 2005 ). Math1 expression is also present in Pax6-positive nuclei such as the pontine nuclei, dorsal nucleus of the lateral lemniscus, laterodorsal tegmental nucleus, and granule cell precursors of external granular layer of developing cerebellum (Machold and Fishell 2005) . It has been reported that Pax6 could bind to particular Math1 regulatory sequences in vitro and exert its regulatory effects on Math1 expression in the lower rhombic lip (Hufnagel et al. 2007) .
Another characteristic feature of Pax6 expressing nuclei is that most of them express Wnt1, one of the canonical Wnt genes. Robust expression of Wnt1 was observed in the major precerebellar nuclei, hindbrain sensory nuclei, and hindbrain monoamine nuclei (Fu et al. 2011 ). Wnt1 emanates from the isthmic organizer and is required for the midbrain development and cerebellar morphogenesis (Liu and Joyner 2001; Schuller and Rowitch 2007) . It functions to stabilize its intracellular signaling molecule b-catenin which is required for cerebellar morphogenesis. Several reports demonstrated that conditional or sustaining expression of b-catenin could result in expansion of Pax6 expression in the developing neocortex (Backman et al. 2005; Wrobel et al. 2007 ), maintenance of the proliferative state, and repression of differentiation of neural progenitor cells (Wrobel et al. 2007; Wexler et al. 2009 ). Pax6 has not been reported as a direct transcriptional target of b-catenin in the brain, but Pax6 is found to down-regulate canonical Wnt signaling in the presumptive lens ectoderm via directly controlling expression of several Wnt inhibitors such as Sfrp1, Sfrp2, and Dkk1 in the presumptive lens (Machon et al. 2010) . Therefore, the roles of Wnt1-bcatenin system in the development of the cerebellum and the nuclei of the hindbrain and remain to be elucidated further.
